O'Shaughnessy Ventures (OSV), known for supporting seed and pre-seed startups, has announced its investment in Hegel AI.

Founded in 2023, Hegel is dedicated to creating a developer-friendly platform geared towards the advancement of generative AI applications.

With its inaugural platform launch, PromptTools, Hegel AI is setting the stage for enhanced interaction with AI models.

PromptTools allows for experimentation with prompts and fine-tuning of models, facilitating the creation of advanced AI applications.

Hegel's commitment to improving the AI development process is evident in its plans to further enhance prompt and model efficacy through online monitoring and evaluation.

Jim O'Shaughnessy, the founder of OSV, expressed his confidence in open source AI's potential.

"Open source is the future of AI, and Hegel is equipping developers with essential tools to revolutionize various industries," he said.

This investment reflects OSV's ongoing commitment to empowering developers with open source, transformative technologies.

Steve Krawczyk, co-founder of Hegel AI, shared his gratitude.

"OSV's investment is a validation of our vision. Their track record in promoting open source, developer-centric products aligns perfectly with our goals," he noted.


The investment from O'Shaughnessy Ventures in Hegel AI marks a significant step in nurturing the growth of open source AI technology.

Through this collaboration, Hegel AI is poised to make significant contributions to the field of AI, potentially reshaping the landscape of AI application development and usage.

Disclosure: Morning Tick is an online publisher focused on the emerging tech niche; we operate with a collaborative approach. In addition to our regular editorial content—both long-form and news—we provide a platform for startups, businesses, and innovation ecosystems to share announcements, offer insights, and showcase products-services. External content is clearly tagged as ‘Partner News’ or ‘Partner Perspectives’ as part of our paid partnership initiative. Learn more on our disclaimer page.